EUVIMEDEUVIMED entdecken
Leserbrief

FLT ‐3 mutation maybe an inferior predictor of daratumumab therapy in acute myeloid leukemia patients relapsed after allogeneic stem cell transplantation

Song Xue iD, Wenqiu Huang, Yongping Zhang, Fuhong Liu, Qi Hao, Jiajun Hu, Lei Yuan, Jingbo Wang iD

International Journal of Laboratory Hematology · 2024

DOI: 10.1111/ijlh.14275 ↗

Kurz gefasst

Leserbrief in der Zeitschrift International Journal of Laboratory Hematology, 2024. Verfasst von Song Xue und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Aerospace Center Hospital, Beijing, China. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Antibodies, Monoclonal, fms-Like Tyrosine Kinase 3, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteAntibodies, Monoclonalfms-Like Tyrosine Kinase 3Hematopoietic Stem Cell TransplantationMutationHumansFemaleMaleTransplantation, HomologousRecurrenceMiddle AgedAdult

Substanzen

daratumumabAntibodies, Monoclonalfms-Like Tyrosine Kinase 3FLT3 protein, human

Autor:innen und Institutionen

  • Department of Hematology, Aerospace Center Hospital, Beijing, China.
  • Department of Hematology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Sh…

ORCID-Profile: Song Xue, Jingbo Wang

Zitieren

APA

Xue, S., Huang, W., Zhang, Y., Liu, F., Hao, Q., Hu, J., Yuan, L., & Wang, J. (2024). FLT ‐3 mutation maybe an inferior predictor of daratumumab therapy in acute myeloid leukemia patients relapsed after allogeneic stem cell transplantation. International Journal of Laboratory Hematology. https://doi.org/10.1111/ijlh.14275

Vancouver

Xue S, Huang W, Zhang Y, Liu F, Hao Q, Hu J, et al. FLT ‐3 mutation maybe an inferior predictor of daratumumab therapy in acute myeloid leukemia patients relapsed after allogeneic stem cell transplantation. International Journal of Laboratory Hematology. 2024. doi:10.1111/ijlh.14275

BibTeX
@article{Xue2024,
  author = {Xue, Song and Huang, Wenqiu and Zhang, Yongping and Liu, Fuhong and Hao, Qi and Hu, Jiajun and Yuan, Lei and Wang, Jingbo},
  title = {FLT ‐3 mutation maybe an inferior predictor of daratumumab therapy in acute myeloid leukemia patients relapsed after allogeneic stem cell transplantation},
  journal = {International Journal of Laboratory Hematology},
  year = {2024},
  doi = {10.1111/ijlh.14275}
}
Kostenlos starten →